OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production from Chinese hamster ovary (CHO) cells remains a paramount challenge with the biopharmaceutical industry. Various strategies are employed enhance antibody titer, including process parameter optimization, cell line development, and implementation of perfusion processes. Fine-tuning media composit